We Can Medicines Co (ROCO:6929) ROCE % : -4.96% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is We Can Medicines Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. We Can Medicines Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -4.96%.

We Can Medicines Co ROCE % Historical Data

The historical data trend for We Can Medicines Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

We Can Medicines Co ROCE % Chart

We Can Medicines Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

4.77

4.08

9.02

2.58

-1.05

We Can Medicines Co Quarterly Data
	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial									3.18	4.26	0.11	-2.85	-4.96

We Can Medicines Co ROCE % Calculation

We Can Medicines Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-20.865	/	( ( (2860.853 - 1045.095)	+	(3085.594 - 921.387) )	/ 2 )
	=	-20.865	/	( (1815.758	+	2164.207)	/ 2 )
	=	-20.865	/	1989.9825
	=	-1.05 %

We Can Medicines Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-109.144	/	( ( (3135.171 - 897.927)	+	(3085.594 - 921.387) )	/ 2 )
	=	-109.144	/	( ( 2237.244	+	2164.207 )	/ 2 )
	=	-109.144	/	2200.7255
	=	-4.96 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

We Can Medicines Co (ROCO:6929) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

We Can Medicines Co ROCE % Related Terms

Thank you for viewing the detailed overview of We Can Medicines Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

We Can Medicines Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » We Can Medicines Co Ltd (ROCO:6929) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 4, Taiwan Avenue, 20th Floor-1, No. 925, Xitun District, Taichung, TWN

Website

http://www.yourchance.com.tw

We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.

We Can Medicines Co Headlines

No Headlines